Recursion Pharmaceuticals
RXRX
#4101
Rank
NZ$3.81 B
Marketcap
$9.81
Share price
-4.80%
Change (1 day)
-13.63%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$0.15 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's total debt is NZ$0.15 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Recursion Pharmaceuticals - Total debt on balance sheet (from 2020 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$80.12 M-0.26%
2022-12-31NZ$80.33 M378.07%
2021-12-31NZ$16.8 M-22.58%
2020-12-31NZ$21.7 M-9.59%
2019-12-31NZ$24 M